
Neuropediatrician highlights the potential of full spectrum cannabidiol, but access still faces judicial and bureaucratic barriers

Studies point to the substance's effectiveness in reducing anxious symptoms, but experts advocate caution and more clinical research

City Hall program includes over 30 diseases and ensures free medication at municipal network pharmacies

Event at Uece brought together experts, family members, and researchers to discuss scientific evidence and innovations in the use of CBD in the treatment of autism

Research conducted on mice at the Ribeirão Preto School of Dentistry showed that the substance had a selective antipyretic effect

Understand cannabidiol, its functioning in the body, and potential therapeutic benefits

With clinical sensitivity and active listening, a pediatrician reports how cannabidiol has transformed the lives of children with epilepsy, autism, and other complex neurological conditions, as well as their families

New solid and water-soluble presentation arrives at Brazilian pharmacies after three years of research

The measure, built in dialogue with the government, aims to support families and ensure access to treatments for various health conditions

Ease Labs is the second among the five companies with the highest market volume to announce price reductions

Diagnosed with multiple sclerosis, the content creator found in the use of light cannabis and daily affection ways to reinvent her own time and rediscover lightness

A 55-year-old patient in Campo Grande obtained free access to the medication after action by the Public Defender's Office of MS

Study by USP and Fiocruz shows that cannabidiol may reverse symptoms associated with autism in an animal model, paving the way for new treatments of ASD

The Health Department of the Federal District has opened a bidding process for the purchase of cannabidiol-based medication, intended for patients with severe epilepsy treated by SUS-DF

Deputy criticizes state bureaucracy and advocates for free supply of cannabis-based medicines through SUS in Santa Catarina

Researchers identify three new cannabinoids, cannabisol, canabitwinol, and canabizetol, with promising therapeutic properties, expanding the boundaries of science on Cannabis sativa

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

Pioneering initiative in Brazil is nationally recognized for its impact on healthcare assistance and already benefits 247 patients in the state

An analysis of the compounds that shape the flavor, aroma, and effects of the plant, focusing on the national scenario